Onxeo S.A. buy exploration
Summary
This prediction ended on 12.09.17 with a price of €1.94. Massive losses of -53.25% were the result for the BUY prediction by exploration. exploration has 50% into this predictionOnxeo is a cutting-edge biotechnology company that specializes in the research and development of novel drugs to treat patients with rare or resistant cancers. Headquartered in Paris, France, this innovative firm has established itself as a leader in the field by leveraging its advanced platform, known as DNA Therapeutics, in conjunction with a comprehensive portfolio of small molecules and orphan oncology assets. With a strong commitment to scientific excellence and a robust intellectual property strategy, Onxeo aims to improve patient outcomes by addressing critical unmet medical needs and creating value for stakeholders through strategic partnerships and licensing deals.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Onxeo S.A. | 0.000% | 0.000% | -62.656% | -85.124% |
| iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
| iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
| iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
| iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by exploration for this prediction
In the thread Onxeo S.A. diskutieren
Onxeo: Abprall an 4€ Marke
ich setze auf ein Pull back der 4€. erstes Ziel unter 5,1€.
hält die nicht, dann sofort verkaufen Ziel 3€.